1. Home
  2. ARTL vs EPWK Comparison

ARTL vs EPWK Comparison

Compare ARTL & EPWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARTL
  • EPWK
  • Stock Information
  • Founded
  • ARTL 2011
  • EPWK 2011
  • Country
  • ARTL United States
  • EPWK China
  • Employees
  • ARTL 6
  • EPWK N/A
  • Industry
  • ARTL Biotechnology: Pharmaceutical Preparations
  • EPWK
  • Sector
  • ARTL Health Care
  • EPWK
  • Exchange
  • ARTL Nasdaq
  • EPWK Nasdaq
  • Market Cap
  • ARTL 8.4M
  • EPWK 9.5M
  • IPO Year
  • ARTL N/A
  • EPWK 2025
  • Fundamental
  • Price
  • ARTL $3.97
  • EPWK $0.08
  • Analyst Decision
  • ARTL Buy
  • EPWK
  • Analyst Count
  • ARTL 2
  • EPWK 0
  • Target Price
  • ARTL $30.00
  • EPWK N/A
  • AVG Volume (30 Days)
  • ARTL 69.0K
  • EPWK 73.0M
  • Earning Date
  • ARTL 11-11-2025
  • EPWK 11-11-2025
  • Dividend Yield
  • ARTL N/A
  • EPWK N/A
  • EPS Growth
  • ARTL N/A
  • EPWK N/A
  • EPS
  • ARTL N/A
  • EPWK N/A
  • Revenue
  • ARTL N/A
  • EPWK $20,164,008.00
  • Revenue This Year
  • ARTL N/A
  • EPWK N/A
  • Revenue Next Year
  • ARTL N/A
  • EPWK N/A
  • P/E Ratio
  • ARTL N/A
  • EPWK N/A
  • Revenue Growth
  • ARTL N/A
  • EPWK 10.25
  • 52 Week Low
  • ARTL $3.91
  • EPWK $0.07
  • 52 Week High
  • ARTL $28.60
  • EPWK $26.00
  • Technical
  • Relative Strength Index (RSI)
  • ARTL 32.84
  • EPWK 28.31
  • Support Level
  • ARTL $3.94
  • EPWK $0.07
  • Resistance Level
  • ARTL $4.54
  • EPWK $0.12
  • Average True Range (ATR)
  • ARTL 0.35
  • EPWK 0.04
  • MACD
  • ARTL 0.06
  • EPWK -0.00
  • Stochastic Oscillator
  • ARTL 2.91
  • EPWK 3.50

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

About EPWK EPWK Holdings Ltd. Class A Ordinary Shares

EPWK Holdings Ltd create an innovative and efficient crowdsourcing platform to connect businesses with great talents. It operates online marketplace to enable businesses (buyers) and service providers (sellers) to find each other. The platform users consist of buyers who seek talents for their jobs and sellers who offer different talents and skills. The company derives revenue mainly comes from providing various value-added services for users on both supply and demand sides.

Share on Social Networks: